Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Fujisawa

Showing results (381-390 of 724) with videos related to

Pageof 73
Sort By:
Lower Urinary Tract Symptoms|December 18, 2015
Comparison of Naftopidil 75 mg with Tamsulosin Hydrochloride 0.2 mg in the Treatment of Lower Urinary Tract Symptoms with Benign Prostatic HyperplasiaKatsumi Shigemura, Fukashi Yamamichi, Minori Matsumoto, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2017
Shock due to urosepsis: A multicentre studyFukashi Yamamichi, Katsumi Shigemura, Koichi Kitagawa, et al.
International Journal of Clinical Oncology|June 4, 2020
Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumabKotaro Suzuki, Tomoaki Terakawa, Junya Furukawa, et al.
Japanese Journal of Clinical Oncology|May 6, 2021
Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinomaYukari Bando, Junya Furukawa, Tomoaki Terakawa, et al.
Urology|September 19, 2006
Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapyHideaki Miyake, Mototsugu Muramaki, Toshifumi Kurahashi, et al.
Biochemical and Biophysical Research Communications|March 14, 2022
Protective effects of tadalafil against cisplatin-induced spermatogenic dysfunctionYasuhiro Kaku, Koji Chiba, Katsuya Sato, et al.
Urologic Oncology|March 15, 2011
Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimensYuji Kusuda, Hideaki Miyake, Hosny M Behnsawy, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 21, 2010
Age at diagnosis as a powerful predictor for disease recurrence after radical nephrectomy in Japanese patients with pT1 renal cell carcinomaMototsugu Muramaki, Hideaki Miyake, Iori Sakai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2008
Retroperitoneal abscess perforating into the thoracic cavity in an immunocompromised hostKatsumi Shigemura, Soichi Arakawa, Tetsuya Miura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 27, 2007
Oncological outcome of laparoscopic prostatectomyIsao Hara, Gaku Kawabata, Kazushi Tanaka, et al.
Pageof 73

Showing results (381-390 of 724) with videos related to

Sort By:
Pageof 73
Lower Urinary Tract Symptoms|December 18, 2015
Comparison of Naftopidil 75 mg with Tamsulosin Hydrochloride 0.2 mg in the Treatment of Lower Urinary Tract Symptoms with Benign Prostatic HyperplasiaKatsumi Shigemura, Fukashi Yamamichi, Minori Matsumoto, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 1, 2017
Shock due to urosepsis: A multicentre studyFukashi Yamamichi, Katsumi Shigemura, Koichi Kitagawa, et al.
International Journal of Clinical Oncology|June 4, 2020
Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumabKotaro Suzuki, Tomoaki Terakawa, Junya Furukawa, et al.
Japanese Journal of Clinical Oncology|May 6, 2021
Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinomaYukari Bando, Junya Furukawa, Tomoaki Terakawa, et al.
Urology|September 19, 2006
Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapyHideaki Miyake, Mototsugu Muramaki, Toshifumi Kurahashi, et al.
Biochemical and Biophysical Research Communications|March 14, 2022
Protective effects of tadalafil against cisplatin-induced spermatogenic dysfunctionYasuhiro Kaku, Koji Chiba, Katsuya Sato, et al.
Urologic Oncology|March 15, 2011
Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimensYuji Kusuda, Hideaki Miyake, Hosny M Behnsawy, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 21, 2010
Age at diagnosis as a powerful predictor for disease recurrence after radical nephrectomy in Japanese patients with pT1 renal cell carcinomaMototsugu Muramaki, Hideaki Miyake, Iori Sakai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2008
Retroperitoneal abscess perforating into the thoracic cavity in an immunocompromised hostKatsumi Shigemura, Soichi Arakawa, Tetsuya Miura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 27, 2007
Oncological outcome of laparoscopic prostatectomyIsao Hara, Gaku Kawabata, Kazushi Tanaka, et al.
Pageof 73